Covalent Small Molecules as Enabling Platforms for Drug Discovery
- PMID: 31833626
- DOI: 10.1002/cbic.201900674
Covalent Small Molecules as Enabling Platforms for Drug Discovery
Abstract
Covalent drugs have experienced significant renewed interest in drug discovery. This resurgence has been accompanied by a better understanding of the reactivity relationships required to engage selective covalent bonds between nucleophilic proteins and electrophilic small molecules. As a result, researchers have come to the realisation that covalent molecules could also represent useful and novel tools aimed at supporting medicinal chemistry programmes. This review surveys the increasing number of drug discovery platforms employing covalent chemistries, and highlights the utility of these techniques for identifying and characterising small molecules and biological targets.
Keywords: ABPP; PROTAC; covalent; fragments; photoaffinity.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
References
-
- J. R. Broach, J. Thorner, Nature 1996, 384 (suppl.), 14-16.
-
- C. W. Murray, D. C. Rees, Nat. Chem. 2009, 1, 187-192.
-
- D. E. Scott, A. G. Coyne, S. A. Hudson, C. Abell, Biochemistry 2012, 51, 4990-5003.
-
- R. A. Goodnow, Jr., C. P. Davie in Annual Reports in Medicinal Chemistry, Vol. 50 (Ed.: R. A. Goodnow, Jr.) Elsevier, Amsterdam, 2017, pp. 1-15.
-
- J. G. Moffat, F. Vincent, J. A. Lee, J. Eder, M. Prunotto, Nat. Rev. Drug Discovery 2017, 16, 531-543.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
